We present a commentary on the inclusion criteria and outcome measures of the major randomized trials on multiple sclerosis. A qualitative comparison of the characteristics of the enrolled patients is done. The objective is to stimulate a discussion about the need to improve research strategies. The discovery of new drugs studied without personalized criteria does not allow for useful advances in knowledge.
Avolio, C., Centonze, D. (2021). Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful. NEUROLOGY AND THERAPY [10.1007/s40120-021-00291-y].
Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful
Centonze, Diego
2021-10-30
Abstract
We present a commentary on the inclusion criteria and outcome measures of the major randomized trials on multiple sclerosis. A qualitative comparison of the characteristics of the enrolled patients is done. The objective is to stimulate a discussion about the need to improve research strategies. The discovery of new drugs studied without personalized criteria does not allow for useful advances in knowledge.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Avolio-Centonze2021_Article_PivotalTrialsInMultipleScleros.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
238.92 kB
Formato
Adobe PDF
|
238.92 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
